document.write("
"); document.write("
Hoerber,\ S.*\ ; Rettig,\ I.*\ ; Peter,\ A.
"); document.write("
Mitotic figure in the peripheral blood smear.
"); document.write("
Am. J. Hematol. 93, 154-154 (2018)
"); document.write("
"); document.write("
"); document.write("
Massner,\ C.\ ; Pariani,\ G.\ ; Rolbieski,\ H.\ ; Sigmund,\ F.\ ; Westmeyer,\ G.G.
"); document.write("
Genetically controlled uptake of ferritin as an MRI contrast agent.
"); document.write("
Am. J. Hematol. 91, E119 (2016)
"); document.write("
"); document.write("
"); document.write("
Muendlein,\ A.*\ ; Kinz,\ E.*\ ; Gasser,\ K.*\ ; Leiherer,\ A.*\ ; Rein,\ P.*\ ; Saely,\ C.H.*\ ; Grallert,\ H.\ ; Peters,\ A.\ ; Fraunberger,\ P.*\ ; Drexel,\ H.*\ ; Lang,\ A.H.*
"); document.write("
Occurrence of the \JAK2 V617F\ mutation in patients with peripheral arterial disease.
"); document.write("
Am. J. Hematol. 90, E17-E21 (2015)
"); document.write("
"); document.write("
"); document.write("
Muendlein,\ A.*\ ; Gasser,\ K.*\ ; Kinz,\ E.*\ ; Stark,\ N.*\ ; Leiherer,\ A.*\ ; Rein,\ P.*\ ; Saely,\ C.H.*\ ; Grallert,\ H.\ ; Peters,\ A.\ ; Drexel,\ H.*\ ; Lang,\ A.H.*
"); document.write("
Evaluation of the prevalence and prospective clinical impact of the \JAK2\ \V617F\ mutation in coronary patients.
"); document.write("
Am. J. Hematol. 89, 295-301 (2014)
"); document.write("
"); document.write("
"); document.write("
Muehlschlegel,\ J.D.*\ ; Perry,\ T.E.*\ ; Liu,\ K.Y.*\ ; Fox,\ A.A.*\ ; Smith,\ S.A.*\ ; Lichtner,\ P.\ ; Collard,\ C.D.*\ ; Shernan,\ S.K.*\ ; Hartwig,\ J.H.*\ ; Body,\ S.C.*\ ; Hoffmeister,\ K.M.*
"); document.write("
Polymorphism in the protease-activated receptor-4 gene region associates with platelet activation and perioperative myocardial injury.
"); document.write("
Am. J. Hematol. 87, 161-166 (2012)
"); document.write("
");